Advertisement

Expression of Normal Differentiation Antigens on Human Leukemias and Lymphomas

  • Lee M. Nadler
  • Jerome Ritz
  • Ellis L. Reinherz
  • Stuart F. Schlossman
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 57)

Abstract

Leukemias and lymphomas are presently classified according to morphologic and histochemical criteria. (1–7). Although attempts to catalogue tumors according to these criteria have provided important insights into their presentation, clinical course, and response to therapy, a single universally accepted classification system is currently lacking. Moreover, within each histologically defined subgroup there is considerably greater clinical heterogeneity than has been define able by either morphology or histochemistry. In the last decade, cell surface markers have provided an alternative means to identify normal lymphoid and myeloid cells possessing unique biologic properties. The application of these markers to the classification of lymphoid and myeloid tumors promises to complement presently existing classification schemes.

Keywords

Cell Surface Marker Human Leukemia Cell Surface Antigen Null Cell Lymphoblastic Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hayhoe, F.G.J, and Flemans, R.J. (1970). In “An Atlas of Haematological Cytology”, pp. 110–265. Wiley-Interscience, New York.Google Scholar
  2. 2.
    Hayhoe, F.G.J., Quagliano, M. and Doll, R. (1964). “The Cytology and Cytochemistry of Acute Leukemias: A Study of 140 Cases”. Her Majesty’s Stationery Office, London.Google Scholar
  3. 3.
    Rappaport, H. (1966). In “Atlas of Tumor Pathology”. Section 3, Fascicle 9, p. 13. Armed Forces Institute of Pathology, Washington, D.C.Google Scholar
  4. 4.
    Braylan, R.C., Jaffe, E.S. and Berard, C.W. (1975). Pathol. Annu. 10, 213–270.Google Scholar
  5. 5.
    Bennett, J.M., Catovsky, D., Daniel, M.T. et al. (1976). Br. J. Haematol. 33, 451–458.CrossRefGoogle Scholar
  6. 6.
    Gralnick, H.R., Galton, D.A.G., Catovsky, D., Sultan C. and Bennett, J.M. (1977). Ann. Int. Med. 87, 740–753.CrossRefGoogle Scholar
  7. 7.
    Dorfman, R.F. (1977). Cancer Treat. Rep. 61, 945–952.Google Scholar
  8. 8.
    Aisenberg, A.C. and Bloch, K.J. (1972). N. Engl. J. Med. 287, 272–276.CrossRefGoogle Scholar
  9. 9.
    Borella, L. and Sen, L. (1973). J. Immunol. 111, 1257–1261.Google Scholar
  10. 10.
    Brouet, J.C. and Seligmann, M. (1978). Cancer 42, 817–827.CrossRefGoogle Scholar
  11. 11.
    Siegal, F.P. (1978). “The Immunopathology of Lymphoreticular Neoplasms” (Ed. J.J. Twommey and R.A. Good), pp. 281–324. Plenum, New York.CrossRefGoogle Scholar
  12. 12.
    Mann, R.B., Jaffe, E.S. and Berard, C.W. (1979). Am. J. Pathol. 94, 104–191.Google Scholar
  13. 13.
    Gathings, W.E., Lawton, A.R. and Cooper, M.D. (1977). Eur. J. Immunol. 7, 804–810.CrossRefGoogle Scholar
  14. 14.
    Froland, S.S. and Natvig, J.B. (1970). Int. Arch. Allerg. & Appl. Immunol. 39, 121–132.CrossRefGoogle Scholar
  15. 15.
    Froland, S.S., Natvig, J.B. and Berdal, P. (1971). Nature 234, 251–252.Google Scholar
  16. 16.
    Huber, H., Douglas, S.D. and Fidenberg, H.H. (1969). Immunol. 17, 7–21.Google Scholar
  17. 17.
    Bianco, C., Patrick, R. and Nussenzweig, V. (1970). J. Exp. Med. 132, 702–720.CrossRefGoogle Scholar
  18. 18.
    Dickler, H.B. and Kunkel, H.G. (1972). J. Exp. Med. 136, 191–196.CrossRefGoogle Scholar
  19. 19.
    Bianco, C., Patrick, R. and Nussenzweig, V. (1970). J. Exp. Med. 132, 702–720.CrossRefGoogle Scholar
  20. 20.
    Winchester, R.J., Fu, S.M., Wernet, P., Kunkel, H.G., Dupont, B. and Jerslid, C. (1975). J. Exp. Med. 141, 924–929.Google Scholar
  21. 21.
    Schlossman, S.F., Chess, L., Humphreys, R.E. and Strominger, J.L. (1976). Proc. Natl. Acad. Sci. USA 73, 1288–1292.CrossRefGoogle Scholar
  22. 22.
    Jondal, M., Holm, G. and Wigzell, H. (1972). J. Exp. Med. 136, 207–215.CrossRefGoogle Scholar
  23. 23.
    Pratt, D.M., Schlossman, S.F. and Strominger, J.L. (1980), J. Immunol. 124, 1449–1461.Google Scholar
  24. 24.
    Chess, L. and Schlossman, S.F. (1977). In “Advances in Immunology” (Ed. F.J. Dixon and H.G. Kunkel), pp. 213–247. Academic Press, Inc., New York.Google Scholar
  25. 25.
    Winchester, R.J., Fu, S.M. and Kunkel, H.G. (1975). J. Immunol. 114, 1210–1212.Google Scholar
  26. 26.
    Mendes, N.F., Tolnai, M.C.A., Silvefra, N.P.A., Gilbertsen, R.B. and Metzgar, R.S. (1973). J. Immunol. 111, 860–867.Google Scholar
  27. 27.
    Evans, R.L., Faldetta, T.J., Humphreys, R.E., Pratt, D.M., Yunis, E.J. and Schlossman, S.F. (1978). J. Exp. Tied. 148, 1440–1445.CrossRefGoogle Scholar
  28. 28.
    Reinherz, E.L., Kung, P.C., Pesando, J.M., Goldstein, G. and Schlossman, S.F. (1979). J. Ext. Med. 150, 1472–1482.CrossRefGoogle Scholar
  29. 29.
    Kohler, G. and Milstein, C. (1975). Nature 256, 495–497.CrossRefGoogle Scholar
  30. 30.
    Ross, G.D., Rabellino, E.M., Polley, M.D. and Grey, H.M. (1973). J. Clin. Invest. 52, 377–384.CrossRefGoogle Scholar
  31. 31.
    Borella, L. and Sen, L. (1975). J. Immunol. 114, 187–190.Google Scholar
  32. 32.
    Jaffe, E.S., Shevach, E.M., Sussman, E.H., Frank, M., Green, I. and Berard, C.W. (1975). Br. J. Cancer 31, (suppl. 2), 107–120.Google Scholar
  33. 33.
    Moretta, L., Webb, S.R., Grossi, C.E., Lydyard, P.M. and Cooper M.D. (1977). J. Exp. Med. 146, 184–200.CrossRefGoogle Scholar
  34. 34.
    Moretta, L., Ferrarini, M., Mingari, M.C., Moretta, A. and Webb, S.R. (1977). J. Immunol. 117, 2171–2174.Google Scholar
  35. 35.
    Moretta, L., Mingari, M.C., Moretta, A. and Lydyard, P.M. (1977) Clin. Immunol. Immunopathol. 7, 405–409.CrossRefGoogle Scholar
  36. 36.
    Chechik, B.E., Pyke, K.W. and Gelfand, E.W. (1976). Int. J. Cancer 18, 551–556.CrossRefGoogle Scholar
  37. 37.
    Borella, L., Sen, L., Dow, L.W. and Casper, J.T. (1977). In “Hematology and Blood Transfusion”, p. 77. Springer, Berlin.Google Scholar
  38. 38.
    Boumsell, L., Bernard, A., Coppin H., et al. (1979). J. Immunol. 123, 2063–2067.Google Scholar
  39. 39.
    Evans, R.L., Breard, J.M., Lazarus, H., Schlossman, S.F. and Chess, L. (1977). J. Exp. Med. 145, 221–233.CrossRefGoogle Scholar
  40. 40.
    Evans, R.L., Lazarus, H., Penta, A. C. and Schlossman, S.F. (1978). J. Immunol. 129, 1423–1428.Google Scholar
  41. 41.
    Reinherz, E.L. and Schlossman, S.F. (1979). J. Immunol. 122, 1335–1341.Google Scholar
  42. 42.
    Reinherz, E.L. and Schlossman, S.F. (1980). Cell 19, 821–827.CrossRefGoogle Scholar
  43. 43.
    Reinherz, E.L., Kung, P.C., Goldstein, G., Levey, R.H. and Schlossman, S.F. (1980). Proc. Natl. Acad. Sci. USA 77, 1588–1592.CrossRefGoogle Scholar
  44. 44.
    Reinherz, E.L. and Schlossman, S.F. (in press). Cancer Res.Google Scholar
  45. 45.
    Boyse, E.A., Stockert, E., and Old, L.J. (1967). Proc. Natl. Acad. Sci. USA 58, 954–957.CrossRefGoogle Scholar
  46. 46.
    Reinherz, E.L., Kung, P.C., Goldstein, G. and Schlossman, S.F. (1979). Proc. Nat. Acad. Sci. USA 76, 4061–4065.CrossRefGoogle Scholar
  47. 47.
    Reinherz, E.L., Kung, P.C., Goldstein, G. and Schlossman, S.F. (1979). J. Immunol. 123, 2894–2896.Google Scholar
  48. 48.
    Reinherz, E.L., Kung, P.C., Goldstein, G. and Schlossman, S.F. (1980). J. Immunol. 124, 1301–1307.Google Scholar
  49. 49.
    Bhan, A.K., Reinherz, E.L., Poppema, S., McCluskey, R.T. and Schlossman, S.F. (1980). J. Exp. Med. 152, 771–782.CrossRefGoogle Scholar
  50. 50.
    Janossy, G., Tidman, N., Selby, W.S., et al. (1980). Nature 288, 81–84.CrossRefGoogle Scholar
  51. 51.
    Reinherz, E.L., Nadler, L.M., Sail an, S.E. and Schlossman, S.F. J. Clin. Invest. 64, 392–397.Google Scholar
  52. 52.
    Nadler, L.M., Reinherz, E.L., Weinstein, H.J., D’Orsi, C.J. and Schlossman, S.F. (1980). Blood 55, 806–810.Google Scholar
  53. 53.
    Nadler, L.M., Reinherz, E.L. and Schlossman, S.F. (1980). Cancer Chemother. Pharmocol. 4, 11–15.Google Scholar
  54. 54.
    Bernard, A., Boumsell, L., Reinherz, E.L., et al. (1981) Blood, 57, 1105–1110.Google Scholar
  55. 55.
    Nathwani, B.N., Kim, H. and Rappaport, H. (1976). Cancer 38, 984–985.CrossRefGoogle Scholar
  56. 56.
    Jaffe, E.S. and Berard, C.W. (1978). Ann. Int. Med. 89, 415–416.CrossRefGoogle Scholar
  57. 57.
    Rosen, P.J., Feinstein, D.I., Pattengale, P.K., et al. (1978) Ann. Int. Med. 89, 319–324.CrossRefGoogle Scholar
  58. 58.
    Reinherz, E.L., Nadler, L.M., Rosenthal, D.S., Moloney, W.C. and Schlossman, S.F. (1979). Blood 53, 1066–1075.Google Scholar
  59. 59.
    Boumsell, L., Bernard, A., Reinherz, E.L., et al. (1981) Blood 57, 526–530.Google Scholar
  60. 60.
    Brooks, D.A., Beckman, I., Bradley, J., McNamara, P.J., Thomas, M.E. and Zola, H. (1980). Clin. Exp. Immunol. 39, 477–485.Google Scholar
  61. 61.
    Stashenko, P., Nadler, L.M., Hardy, R. and Schlossman, S.F. (1980). J. Immunol. 125, 1678–1685.Google Scholar
  62. 62.
    Nadler, L.M., Stashenko, P., Hardy, R., van Agthoven, A., Terhorst, C. and Schlossman, S.F. (1981) J. Immunol. 126, 1941–1947.Google Scholar
  63. 63.
    Greaves, M.F., Verbi, W., Kemshead, J. and Kennett, R. (1980). Blood 56, 1141–1144.Google Scholar
  64. 64.
    Abramson, C., Kersey, J. and LeBien, T. (1981). J. Immunol. 126, 83–88.Google Scholar
  65. 65.
    Stashenko, P., Nadler, L.M., Hardy, R. and Schlossman, S.F. (1981), Proc. Nat. Acad. Sci. 78, 3848–3852.CrossRefGoogle Scholar
  66. 66.
    Fauci, A.S., Pratt, K.R.K, and Whalen, G. (1976). J. Immunol. 117, 2100–2104.Google Scholar
  67. 67.
    Salmon, S.E. and Seligmann, M. (1974). Lancet II, 1230–1233.CrossRefGoogle Scholar
  68. 68.
    Nadler, L.M., Stashenko, P., Ritz, J., Hardy, R., Pesando, J.M. and Schlossman, S.F. (1981). J. Clin. Invest. 67, 134–140.CrossRefGoogle Scholar
  69. 69.
    Fu, S.F., Winchester, R.J. and Kunkel, H.G. (1975). J. Exp. Med. 142, 1334–1339.CrossRefGoogle Scholar
  70. 70.
    Chessells, J.M., Hardisty, R.M., Rapson, N.T. and Greaves, M.F. (1977). Lancet 2, 1307–1309.CrossRefGoogle Scholar
  71. 71.
    Sutherland, R., Smart, J., Niaudet, P. and Greaves, M. (1978) Leukemia Research 2, 115–126.CrossRefGoogle Scholar
  72. 70a.
    Greaves, M.F., Brown, G., Rapson, N.T. and Lister, T.A. (1975) Clin. Immunol. Immunopathol. 4, 67–84.CrossRefGoogle Scholar
  73. 71a.
    Borella, L., Sen, L. and Casper, J.T. (1979). Leuk. Res. 3, 353–362.CrossRefGoogle Scholar
  74. 72.
    Billing, R., Monowada, J., Cline, M., Clark, B. and Lee, K. (1978). J. Natl. Cancer Inst. 61, 423–429.Google Scholar
  75. 73.
    Pesando, J.M., Ritz, J., Lazarus, H., Costello, S.B., Sallan, S.E. and Schlossman, S.F. (1979). Blood 54, 1240–1248.Google Scholar
  76. 74.
    Ritz, J., Pesando, J.M., Notis-McConarty, J., Lazarus, H. and Schlossman, S.F. (1980). Nature (Lond) 283, 583–585.CrossRefGoogle Scholar
  77. 75.
    Vogler, L.V., Crist, W.U., Bockman, D.E., Pearl, E.R., Lawton, A.R. and Cooper, M.D. (1978). N. Engl. J. Med. 298, 872–878.CrossRefGoogle Scholar
  78. 76.
    Greaves, M.F., Verbi, W., Vogler, L.B., et al. (1979). Leuk. Res. 3, 353–362.CrossRefGoogle Scholar
  79. 77.
    Brouet, J.C., Preud’homme, J.L., Penit, C., Valensi, F., Rouget, P. and Seligmann, M. (1979). Blood 54, 269–273.Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • Lee M. Nadler
    • 1
    • 2
  • Jerome Ritz
    • 1
    • 2
  • Ellis L. Reinherz
    • 1
    • 2
  • Stuart F. Schlossman
    • 1
    • 2
  1. 1.Div. of Tumor ImmunologySidney Farber Cancer InstituteMassachussettsUSA
  2. 2.Harvard Medical SchoolBostonUSA

Personalised recommendations